The commercial medical insurance sector is poised to welcome its inaugural set of industry-wide standard clauses. On September 16, the China Insurance行业协会 released draft standard clauses for long-term medical insurance, short-term medical insurance, and city-customized commercial medical insurance, commonly known as "Huiminbao", for public feedback.
This marks the first time the three major categories of commercial medical insurance have been consolidated under a unified contract framework. Several industry insiders have noted that this signals an end to the long-standing era of fragmented insurance terms, finally establishing a common baseline that will foster more consistent market understanding and simplify the process for consumers to comprehend and select their options.
In recent years, commercial medical insurance in China has experienced rapid growth, expanding its coverage and strengthening its protective role as a key component of the multi-tiered medical security system. Industry data reveals that in 2024, the scale of commercial medical insurance outpaced critical illness insurance for the first time, becoming the largest segment in the health insurance market.
However, the absence of a standardized contract format has led to a proliferation of products with varying clause lengths and inconsistent wording. Questions such as "when does the waiting period start", "what constitutes reasonable and necessary treatment", and "how broad are the exclusions" often receive different answers across products, leaving consumers grappling with policies they find hard to understand or compare. The introduction of these model clauses directly targets this persistent issue.
This initiative follows the guidance issued in September 2025 by the National Financial Regulatory Administration, which called for the development of standard health insurance clauses to define coverage scope and exclusions, and to push for more standardized, accessible, and simplified terms. The draft specifies uniform definitions for 24 commonly used concepts, including "initial application", "reasonable and necessary", "confirmed first occurrence", and "specialist doctor".
It also standardizes the presentation of key elements such as waiting periods, deductibles, benefit limits, designated medical institution types, and benefits schedules, while leaving certain specifics for insurers to fill in themselves. One health insurance professional explained that medical insurance is a unique product, allowing life, property, and health insurers to participate, each bringing different underwriting logics. This diversity contributes to the confusion consumers often experience, underscoring the need for a degree of standardization, much like the highly uniform auto insurance market.
According to Long Ge, deputy director of the Innovation and Risk Management Research Center at the University of International Business and Economics, the core purpose of these draft clauses is to unify industry standards and eliminate the previous inconsistencies that fueled consumer confusion. He described this as a foundational step to regulate the commercial medical insurance field, benefiting long-term industry discipline and promoting transparent consumer practices.
Consumer protection is a major focus of the draft. It regulates exclusion clauses by requiring prominent marking to highlight key points, and outlines eight standard exclusions, including war and drunk driving, while encouraging insurers to minimize additional restrictions. The draft also standardizes claims application materials and processing timelines, clarifies how deductibles are applied, and encourages flexibility in the designated medical institution network during emergencies.
The benefits schedule is now designated as a critical part of the contract, with standardized tables to visualize core coverage information. For short-term insurance, the draft explicitly states that coverage is not guaranteed for renewal. For long-term products with adjustable premiums, it details the triggers, timing, caps, procedures, and disclosure obligations for any adjustments. Long Ge anticipates that the implementation of these clauses will significantly reduce disputes, protect consumer rights, and shift the industry's focus from opaque practices to tangible protection and service quality.
Regarding coverage for specific drugs, the draft mandates that any list of designated medicines must include the commercial health insurance drug list published by the China Insurance行业协会. Insiders suggest this implies the association will release its own specialty drug list, though its relationship with the commercial insurance innovative drug catalogue currently managed by the medical security authorities remains to be clarified.
The draft structures the model clauses into three parts: basic items, which insurers must adopt verbatim; optional items, which if selected must also be included in full; and blank sections for insurers to customize. The association emphasized that while allowing insurers to add content based on practical needs, this approach balances standardization with flexibility. However, the health insurance professional noted that the draft primarily addresses general terms, and further implementation guidelines will be needed to clarify how these clauses are applied and whether they might constrain future product innovation.
Comments